Hippo T&C Unveils Three Self-Developed Digital Therapeutic Devices
On the 31st, Hippo T&C, led by CEO Tai-Myoung Chung, hosted a showcase at the Four Seasons Hotel in Jongno-gu, Seoul, where they introduced their newly developed digital diagnostic and therapeutic devices to various industry experts.
During the event, Hippo T&C presented three of their completed digital therapeutic devices: AttnKare-D, AttnKare-T, and BlueKare-T. The showcase featured a lecture titled "A to Z of ADHD" by Dr. Jeffrey Newcorn, a world-renowned ADHD expert from Mount Sinai Hospital in New York, as well as an inauguration ceremony for the Hippo Family.
AttnKare-D, an ADHD diagnostic device, uses virtual reality (VR) to collect data, which is then analyzed in real-time by artificial intelligence (AI) to provide reliable results. It offers a simple report for caregivers and detailed behavior change insights for doctors. It is currently undergoing clinical trials with the approval of the Ministry of Food and Drug Safety and is preparing for trials at the University of Nebraska Medical Center and Mount Sinai Hospital.
AttnKare-T is a personalized digital therapeutic device for ADHD, offering tailored treatment features based on patient characteristics. It includes 10 mini-games and 2 racing games, designed with a medical evidence-based approach to benefit children with ADHD.
Additionally, Hippo T&C has completed the development of BlueKare-T, an augmented reality (AR) app that helps alleviate depression through AI chatbots, exercise, and deep breathing. The app has been submitted to the Ministry of Food and Drug Safety for confirmatory clinical trials.
The company is also planning to launch two wellness products in May: ‘iHQTest,’ a simple screening tool for ADHD, and ‘MindStep,’ an app for mood enhancement. These products are based on the core technologies used in their digital therapeutic devices.
As part of the first-phase pilot project, Hippo T&C awarded certificates to 16 selected psychological counseling centers across the country. These centers will be part of the Hippo Family, which will be chosen through a rigorous selection process based on strict criteria. Members of the Hippo Family will receive various benefits and have access to iHQTest and MindStep.
The showcase was attended by prominent figures and medical experts, including former Deputy Prime Minister Oh Myung, KAIST Honorary Professor Kim Jin-Hyung, former Second Vice Minister of Science and ICT Min Won-Ki, Professor Soonjo Hwang (University of Nebraska Medical Center), Professor Beth Cron (Mount Sinai Hospital, New York), Professor Jeon Hong-Jin (Samsung Seoul Hospital), CEO Kang Ki-Seok (Pharmalex), Professor Huh Chan-Young (Bundang Seoul National University Hospital), Professor Park Ji-Woong (Seoul Boramae Hospital), Professor Choi Yeon-Ho (Samsung Seoul Hospital), Professor Oh Soo-Hwan (Samsung Changwon Hospital), Professor Ahn Ji-Hyun (Samsung Seoul Hospital), Professor Jung Kyung-Mi (Yonsei University), and former President Shin Dong-Ryul (Sungkyunkwan University), among others.